Efficacy & Safety Study of Natural Eggshell Membrane (NEM) for the Treatment of Joint & Connective Tissue Disorders

Inclusion Criteria: * patients seeking relief of mild to moderate pain due to joint or connective tissue (JCT)disorders. * subjects must have had persistent pain associated with a JCT disorder. * subjects were required to suspend all current pain relief medications. * Subjects that were currently taking analgesic medications were eligible to participate in the studies following a 14 day washout period for NSAIDs, a 7 day washout for narcotics, and a 90 day washout for injected steroids. * subjects currently taking glucosamine, chondroitin sulfate or MSM were only eligible after a 3-month washout period. Exclusion Criteria: * Patients were excluded if they were currently receiving remission-inducing drugs such as methotrexate or immunosuppressive medications or had received them within the past 3 months. * body weight 250 pounds or greater. * a known allergy to eggs or egg products. * pregnant or breastfeeding women. * subjects previously enrolled in a study to evaluate pain relief within the past 6 months or currently involved in any other research study involving an investigational product (drug, device, or biologic) or a new application of an approved product, within 30 days of screening.